Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis (original) (raw)
Curtis RE, Rowlings PA, Deeg HJ et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997; 336: 897–904. ArticleCASPubMed Google Scholar
Witherspoon RP, Fisher LD, Schoch G et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989; 321: 784–789. ArticleCASPubMed Google Scholar
Deeg HJ, Socie G . Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood 1998; 91: 1833–1844. CASPubMed Google Scholar
Micallef IN, Lillington DM, Apostolidis J et al. Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies. J Clin Oncol 2000; 18: 947–955. ArticleCASPubMed Google Scholar
Curtis RE, Travis LB, Rowlings PA et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 1999; 94: 2208–2216. CASPubMed Google Scholar
Bhatia S, Louie AD, Bhatia R et al. Solid cancers after bone marrow transplantation. J Clin Oncol 2001; 19: 464–471. ArticleCASPubMed Google Scholar
Baker KS, DeFor TE, Burns LJ et al. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol 2003; 21: 1352–1358. ArticlePubMed Google Scholar
Kolb HJ, Socie G, Duell T et al. Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group. Ann Intern Med 1999; 131: 738–744. ArticleCASPubMed Google Scholar
The Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1998: estimates based on data from 12 population-based cancer registries. Jpn J Clin Oncol 2003; 33: 241–245.
The Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1997: estimates based on data from 12 population-based cancer registries. Jpn J Clin Oncol 2002; 32: 318–322.
The Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1992–93: estimates based on data from seven population-based cancer registries. The Research Group for Population-based Cancer Registration in Japan. Jpn J Clin Oncol 1998; 28: 641–647.
The Research Group for Population-based Cancer Registration in Japan. Cancer incidence in Japan, 1985–89: re-estimation based on data from eight population-based cancer registries. The Research Group for Population-based Cancer Registration in Japan. Jpn J Clin Oncol 1998; 28: 54–67.
Esteve J, Benhamou E, Raymond L . Statistical methods in cancer research. Volume IV. Descriptive epidemiology. IARC Sci Publ 1994; 128: 1–302. Google Scholar
Krishnan A, Bhatia S, Slovak ML et al. Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood 2000; 95: 1588–1593. CASPubMed Google Scholar
Milligan DW, Ruiz De Elvira MC, Kolb HJ et al. Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation. Br J Haematol 1999; 106: 1020–1026. ArticleCASPubMed Google Scholar
Socie G, Henry-Amar M, Cosset JM et al. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood 1991; 78: 277–279. CASPubMed Google Scholar
Socie G, Curtis RE, Deeg HJ et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 2000; 18: 348–357. ArticleCASPubMed Google Scholar
Bhatia S, Ramsay NK, Steinbuch M et al. Malignant neoplasms following bone marrow transplantation. Blood 1996; 87: 3633–3639. CASPubMed Google Scholar
Charles M . UNSCEAR report 2000: sources and effects of ionizing radiation. United Nations Scientific Comittee on the Effects of Atomic Radiation. J Radiol Prot 2001; 21: 83–86. ArticleCASPubMed Google Scholar
Neglia JP, Meadows AT, Robison LL et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 1991; 325: 1330–1336. ArticleCASPubMed Google Scholar
Cohen A, Rovelli A, van Lint MT et al. Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood. Bone Marrow Transplant 2001; 28: 1125–1128. ArticleCASPubMed Google Scholar
Bhatia S, Sather HN, Pabustan OB et al. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood 2002; 99: 4257–4264. ArticleCASPubMed Google Scholar
Hawkins MM, Wilson LM, Burton HS et al. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst 1996; 88: 270–278. ArticleCASPubMed Google Scholar
Tucker MA, D'Angio GJ, Boice Jr JD et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 1987; 317: 588–593. ArticleCASPubMed Google Scholar
Friedman DL, Leisenring W, Schwartz JL et al. Second malignant neoplasms following hematopoietic stem cell transplantation. Int J Hematol 2004; 79: 229–234. ArticlePubMed Google Scholar
Curtis RE, Metayer C, Rizzo JD et al. Impact of chronic GvHD therapy on the development of squamous cell cancers after hematopoietic stem cell transplantation: an international case–control study. Blood 2005; 105: 3802–3811. ArticleCASPubMedPubMed Central Google Scholar
Akpek G, Zahurak ML, Piantadosi S et al. Development of a prognostic model for grading chronic graft-versus-host disease. Blood 2001; 97: 1219–1226. ArticleCASPubMed Google Scholar
Rocha V, Franco RF, Porcher R et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002; 100: 3908–3918. ArticleCASPubMed Google Scholar
Vittorio CC, Schiffman MH, Weinstock MA . Epidemiology of human papillomaviruses. Dermatol Clin 1995; 13: 561–574. ArticleCASPubMed Google Scholar
Sasadeusz J, Kelly H, Szer J et al. Abnormal cervical cytology in bone marrow transplant recipients. Bone Marrow Transplant 2001; 28: 393–397. ArticleCASPubMed Google Scholar
Gmeinhart B, Hinterberger W, Greinix HT et al. Anaplastic squamous cell carcinoma (SCC) in a patient with chronic cutaneous graft-versus-host disease (GVHD). Bone Marrow Transplant 1999; 23: 1197–1199. ArticleCASPubMed Google Scholar
Socie G, Scieux C, Gluckman E et al. Squamous cell carcinomas after allogeneic bone marrow transplantation for aplastic anemia: further evidence of a multistep process. Transplantation 1998; 66: 667–670. ArticleCASPubMed Google Scholar
Forrest DL, Nevill TJ, Naiman SC et al. Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis. Bone Marrow Transplant 2003; 32: 915–923. ArticleCASPubMed Google Scholar
Andre M, Henry-Amar M, Blaise D et al. Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease. Blood 1998; 92: 1933–1940. CASPubMed Google Scholar
Socie G, Henry-Amar M, Devergie A et al. Poor clinical outcome of patients developing malignant solid tumors after bone marrow transplantation for severe aplastic anemia. Leukemia Lymphoma 1992; 7: 419–423. ArticleCASPubMed Google Scholar
Friedberg JW, Neuberg D, Stone RM et al. Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 1999; 17: 3128–3135. ArticleCASPubMed Google Scholar
Favre-Schmuziger G, Hofer S, Passweg J et al. Treatment of solid tumors following allogeneic bone marrow transplantation. Bone Marrow Transplant 2000; 25: 895–898. ArticleCASPubMed Google Scholar